Ticker Details
Kymera Therapeutics, Inc.
IPO Date:	August 21, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$9.79B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.37 | 3.31%
Avg Daily Range (30 D):	$3.24 | 3.45%
Avg Daily Range (90 D):	$2.20 | 2.50%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.85M
Avg Daily Volume (90 D):	.59M

Trade Size
Avg Trade Size (Sh.):	54
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	2,775
Avg Institutional Trade:	$2.96M
Avg Institutional Trade (30 D):	$6.36M
Avg Institutional Trade (90 D):	$5.97M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.22M
Avg Closing Trade (30 D):	$17.41M
Avg Closing Trade (90 D):	$11.63M
Avg Closing Volume:	96.76K

News

Jun 12, 2026 @ 11:00 AM Kymera Therapeutics Presents Phase 1 Data in Healt... Source: Na

Jun 8, 2026 @ 11:00 AM Kymera Therapeutics Presents New Preclinical Lupus... Source: Kymera Therapeutics

May 15, 2026 @ 11:00 AM Kymera Therapeutics Announces Presentations on KT-... Source: Na

May 6, 2026 @ 11:00 AM Kymera Therapeutics to Participate in Upcoming May... Source: Not Specified

Apr 23, 2026 @ 11:00 AM Kymera Therapeutics to Report First Quarter 2026 F... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.69	$-.98	$-3.69
Diluted EPS	$-3.69	$-.98	$-3.69
Revenue	$39.21M	$2.87M	$39.21M
Gross Profit	$M	$M	$M
Net Income / Loss	$-311.35M	$-86.98M	$-311.35M
Operating Income / Loss	$-349.4M	$-97.9M	$-349.4M
Cost of Revenue	$39.21M	$2.87M	$39.21M
Net Cash Flow	$236.76M	$244.07M	$236.76M
PE Ratio